Literature DB >> 26085215

Roles of linear ubiquitinylation, a crucial regulator of NF-κB and cell death, in the immune system.

Katsuhiro Sasaki1, Kazuhiro Iwai1.   

Abstract

Linear ubiquitinylation, a newly identified post-translational modification, is catalyzed by the linear ubiquitin assembly complex (LUBAC), which is composed of three different subunits, HOIL-1L (heme-oxidized IRP2 ligase 1L), HOIP (HOIL-1 interacting protein), and SHARPIN (SHANK-associated RH domain-interacting protein). LUBAC plays a critical role in the activation of nuclear factor-κB (NF-κB) signaling triggered by a variety of stimuli, including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and pathogen-derived components, and in the protection from cell death. Loss of function of SHARPIN in mice triggers chronic inflammation in multiple organs including the skin, as well as immunodeficiency. In humans, mutations in the gene encoding HOIL-1L cause chronic hyperinflammation and immunodeficiency, which are both associated with decreased levels of LUBAC. The linear ubiquitinylation activity of LUBAC is indispensable for B-cell function in mice, and hyperactivation of LUBAC is associated with oncogenesis in certain forms of B-cell lymphoma. In this review, the current understanding of the biochemistry of LUBAC-mediated linear ubiquitinylation and its involvement in the immune system are discussed.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  LUBAC; NF-κB; cell death; inflammation; linear ubiquitinylation; ubiquitin

Mesh:

Substances:

Year:  2015        PMID: 26085215     DOI: 10.1111/imr.12308

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  49 in total

Review 1.  30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology.

Authors:  Qian Zhang; Michael J Lenardo; David Baltimore
Journal:  Cell       Date:  2017-01-12       Impact factor: 41.582

Review 2.  Genomics, Biology, and Human Illness: Advances in the Monogenic Autoinflammatory Diseases.

Authors:  Hirotsugu Oda; Daniel L Kastner
Journal:  Rheum Dis Clin North Am       Date:  2017-08       Impact factor: 2.670

3.  The fructose-2,6-bisphosphatase TIGAR suppresses NF-κB signaling by directly inhibiting the linear ubiquitin assembly complex LUBAC.

Authors:  Yan Tang; Hyokjoon Kwon; Brian A Neel; Michal Kasher-Meron; Jacob B Pessin; Eijiro Yamada; Jeffrey E Pessin
Journal:  J Biol Chem       Date:  2018-04-12       Impact factor: 5.157

4.  SHARPIN at the nexus of integrin, immune, and inflammatory signaling in human platelets.

Authors:  Ana Kasirer-Friede; Winson Tjahjono; Koji Eto; Sanford J Shattil
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-25       Impact factor: 11.205

5.  Genome-wide CRISPR-based gene knockout screens reveal cellular factors and pathways essential for nasopharyngeal carcinoma.

Authors:  Chong Wang; Sizun Jiang; Liangru Ke; Luyao Zhang; Difei Li; Jun Liang; Yohei Narita; Isabella Hou; Chen-Hao Chen; Liangwei Wang; Qian Zhong; Yihong Ling; Xing Lv; Yanqun Xiang; Xiang Guo; Mingxiang Teng; Sai-Wah Tsao; Benjamin E Gewurz; Mu-Sheng Zeng; Bo Zhao
Journal:  J Biol Chem       Date:  2019-05-09       Impact factor: 5.157

6.  TRAIL- and TNF-induced signaling complexes-so similar yet so different.

Authors:  Harald Wajant
Journal:  EMBO J       Date:  2017-04-11       Impact factor: 11.598

7.  All roads lead to ubiquitin.

Authors:  Mads Gyrd-Hansen
Journal:  Cell Death Differ       Date:  2017-07       Impact factor: 15.828

Review 8.  An Update on Autoinflammatory Diseases: Relopathies.

Authors:  Annemarie Steiner; Cassandra R Harapas; Seth L Masters; Sophia Davidson
Journal:  Curr Rheumatol Rep       Date:  2018-05-30       Impact factor: 4.592

Review 9.  Regulation of inflammasomes by ubiquitination.

Authors:  Joseph S Bednash; Rama K Mallampalli
Journal:  Cell Mol Immunol       Date:  2016-04-11       Impact factor: 11.530

Review 10.  Ubiquitin-proteasome signaling in lung injury.

Authors:  Natalia D Magnani; Laura A Dada; Jacob I Sznajder
Journal:  Transl Res       Date:  2018-04-23       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.